Alveolar Soft Part Sarcoma

Search Trials
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Status:
Completed
Last Changed:
Apr 28, 2022
First Changed:
Jun 29, 2006
Disease(s):
Adult Alveolar Soft-part Sarcoma
Intervention(s):
doxorubicin hydrochlorideclinical observationtherapeutic conventional surgery3-dimensional conformal radiation therapyifosfamide
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Status:
Completed
Last Changed:
Dec 4, 2013
First Changed:
Jan 27, 2003
Disease(s):
Ovarian Cancer
Intervention(s):
dactinomycinfilgrastimcarboplatincyclophosphamidedoxorubicin hydrochlorideepirubicin hydrochlorideetoposideifosfamidevincristine sulfateperipheral blood stem cell transplantationradiation therapy
Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
Status:
Completed
Last Changed:
Dec 4, 2013
First Changed:
Jan 27, 2003
Disease(s):
Childhood Malignant Fibrous Histiocytoma of Bone
Intervention(s):
dactinomycincarboplatincyclophosphamideepirubicin hydrochlorideetoposideifosfamidevincristine sulfateadjuvant therapyconventional surgeryneoadjuvant therapybrachytherapyradiation therapy
Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
Status:
Completed
Last Changed:
Jun 19, 2013
First Changed:
Jan 27, 2003
Disease(s):
Childhood Malignant Fibrous Histiocytoma of Bone
Intervention(s):
imatinib mesylate
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Status:
Completed
Last Changed:
Aug 15, 2018
First Changed:
Jun 30, 2010
Disease(s):
Adult Alveolar Soft Part Sarcoma
Intervention(s):
Gamma-Secretase Inhibitor RO4929097Laboratory Biomarker AnalysisPharmacological StudyVismodegib

Connect. Empower. Inspire.